Multicenter, Single-arm, Phase IV Study to Evaluate the Efficacy, Safety of Combined Therapy of Aspirin and High Dose 'IVIG-SN' in Pediatric Patients With Kawasaki Disease.
Phase of Trial: Phase IV
Latest Information Update: 02 Jan 2018
At a glance
- Drugs Immunoglobulin G (Primary) ; Aspirin
- Indications Coronary artery disease; Embolism and thrombosis; Mucocutaneous lymph node syndrome
- Focus Therapeutic Use
- Sponsors GC Pharma; Green Cross
- 02 Jan 2018 According to a GC Pharma media release, Green Cross Corporation rebrands itself to GC Pharma.
- 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Feb 2012 New trial record